Evidence map›Paper›PMID 28593454›Full record

ReviewCerebellum (London, England)2017

Permanent Cerebellar Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a Case Report and Review of Literature.

Fabian H Rossi, Elisa Marie Rossi, Michael Hoffmann, Welwin Liu, Ramon Rodriguez Cruz, Natasha Antonovich, Arash Rezaei, Elizabeth Gonzalez, Maria Clara Franco, Alvaro Estevez and 1 more

Open access · greenAbstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Cerebellum (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Fabian H RossiDepartment of Neurology, Veteran Health Care System, Orlando, FL, 32827, USA. Fabian.Rossi@va.gov.
Elisa Marie RossiDepartment of Neurology, Veteran Health Care System, Orlando, FL, 32827, USA.
Michael HoffmannDepartment of Neurology, Veteran Health Care System, Orlando, FL, 32827, USA.
Welwin LiuDepartment of Neurology, Veteran Health Care System, Honolulu, HI, 96701, USA.
Ramon Rodriguez CruzDepartment of Neurology, Veteran Health Care System, Orlando, FL, 32827, USA.
Natasha AntonovichDepartment of Pharmacy, Veteran Health Care System, Orlando, FL, 32827, USA.
Arash RezaeiUCF Medical School, Orlando, FL, 32827, USA.
Elizabeth GonzalezDepartment of Neurology, Veteran Health Care System, Orlando, FL, 32827, USA.
Maria Clara FrancoBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
Alvaro EstevezBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
Florian ThomasDepartment of Neurology, Veteran Health Care System, St Louis, MO, 63104, USA.
Orlando Health · USUniversity of Central Florida · USVA Pacific Islands Health Care System · USVA St. Louis Health Care System · US

Funding

Not founded study Not founded study
6 · The paper itself

Abstract

This was a study of a 33-year-old man with bipolar disorder treated with lithium who developed cerebellar atrophy after an event of extreme hyperthermia. Unlike previously reported cases of acute cerebellar atrophy after heat stroke, neuroleptic syndrome or lithium toxicity, this case was characterized by a chronic cerebellar atrophy that developed after sepsis-induced hyperthermia in the setting of non-toxic lithium levels. Unique to this case also was the early finding of cerebellar atrophy on MRI 2 weeks after the episode of hyperthermia, long-term neurotoxicity after the novo lithium therapy, and longest follow-up case of chronic cerebellar syndrome after hyperthermia with non-toxic lithium levels.

Indexed as

AdultAntimanic AgentsAtrophyBipolar DisorderCerebellar DiseasesCerebellumFeverHumansLithium CompoundsMaleAntimanic AgentsLithium CompoundsAtaxiaCerebellar degenerationCerebellumDrug toxicityHyperthermiaIntoxicationLithiumLithium carbonateNeurolepticsNeurological sequelNeurotoxicitySerum levelsTherapeutic lithium

Identifiers

PMID28593454
OpenAlexW2624414929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.